Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Feb 1;181(3):264-9.
doi: 10.1164/rccm.200907-1064OC. Epub 2009 Nov 5.

Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer

Affiliations
Comparative Study

Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer

Juan P Wisnivesky et al. Am J Respir Crit Care Med. .

Abstract

Rationale: Radiotherapy (RT) is considered the standard treatment for patients with stage I or II non-small lung cancer who are not surgical candidates because of comorbities or preferences against surgery.

Objectives: To compare the outcomes of patients treated with RT alone with those who were untreated to assess the effect of RT on survival.

Methods: Using the Surveillance, Epidemiology and End Results (SEER) registry linked to Medicare files, we identified 6,065 unresected patients with histologically confirmed stage I and stage II non-small cell lung cancer, diagnosed between 1992 and 2002. We used propensity score methods and instrumental variable analysis to control for the possible effects of known as well as unmeasured confounders.

Measurements and main results: Overall, 59% of patients received RT. The overall and lung cancer-specific survival of unresected patients treated with RT was significantly better compared with the untreated cases (P < 0.0001 for both comparisons). RT was associated with a 6-month improvement in median overall survival. Propensity score analyses showed that RT was associated with improved overall (hazard ratio, 0.74; 95% confidence interval, 0.70-0.78) and lung cancer-specific survival (hazard ratio, 0.73; 95% confidence interval, 0.69-0.78). Instrumental variable analysis also indicated improved outcomes among patients treated with RT.

Conclusions: RT improves survival of elderly patients with unresected stage I or II lung cancer. These results should be confirmed in prospective trials.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Unadjusted overall survival of elderly patients with unresected stage I and II NSCLC according to whether they were treated with radiotherapy (RT). Overall survival was significantly better among patients treated with RT (P < 0.0001). (B) Unadjusted lung cancer-specific survival of elderly patients with unresected stage I and II NSCLC treated with and without RT. Patients treated with RT had significantly better lung cancer specific survival compared with those who were not treated (P < 0.0001).
Figure 1.
Figure 1.
(A) Unadjusted overall survival of elderly patients with unresected stage I and II NSCLC according to whether they were treated with radiotherapy (RT). Overall survival was significantly better among patients treated with RT (P < 0.0001). (B) Unadjusted lung cancer-specific survival of elderly patients with unresected stage I and II NSCLC treated with and without RT. Patients treated with RT had significantly better lung cancer specific survival compared with those who were not treated (P < 0.0001).

Comment in

References

    1. Spiro SG, Porter JC. Lung cancer–where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002;166:1166–1196. - PubMed
    1. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379–392. - PubMed
    1. National comprehensive cancer network. Practice guidelines in oncology. Lung cancer-v.1.2008. Available from: http://www.Nccn.Org/professionals/physician_gls/pdf/esophageal.Pdf. Accessed August 14, 2008.
    1. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198–1205. - PubMed
    1. Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003;41:1–11. - PubMed

Publication types